Ridinilazole for Clostridium difficile Infections: Safety and Efficacy Compared with Vancomycin from the CoDIFy Phase 2 Trial

Ridinilazole for Clostridium difficile Infections: Safety and Efficacy Compared with Vancomycin from the CoDIFy Phase 2 Trial